查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1997179

脑脊髓液引流导管市场：按产品类型、材料、应用、最终用途和分销管道分類的全球市场预测，2026-2032年

Cerebrospinal Fluid Drainage Catheter Market by Product Type, Material, Application, End Use, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，脑脊髓液引流导管市场价值将达到 3.1233 亿美元，到 2026 年将成长至 3.4265 亿美元，到 2032 年将达到 5.6743 亿美元，年复合成长率为 8.90%。

主要市场统计数据
基准年 2025 3.1233亿美元
预计年份：2026年 3.4265亿美元
预测年份 2032 5.6743亿美元
复合年增长率 (%) 8.90%

本文概述了临床需求、技术进步和采购重点如何相互交织，并重新定义了脑脊髓液引流导管在医疗保健服务中的重要性。

脑脊髓液引流导管在神经外科、重症监护和门诊治疗中扮演着至关重要的角色。器械材料、感染控制和操作指南的进步逐渐改变了临床医生对引流导管安全性和功能性的预期。临床医生越来越需要能够精准定位、最大限度减少併发症并与监测系统整合的器械，而医疗系统则优先考虑供应的可靠性、成本效益以及对不断变化的监管标准的符合性。

临床进步、感染控制重点、门诊护理的扩展以及供应链的韧性如何共同改变脑脊髓液引流导管的现况。

脑脊髓液引流导管的市场模式正经历变革，这主要归因于临床、技术和医疗保健系统发展趋势的相互作用。微创技术和影像引导置管技术缩短了手术时间，降低了併发症率，促使临床医生采用更先进的导管设计，以支援标靶治疗和监测。同时，为预防感染所采取的措施也正在加速推广表面技术和可降低器械相关感染的手术通讯协定，进而影响采购决策和临床路径。

评估 2025 年关税趋势将如何重塑脑脊髓液引流导管整个价值链的采购、製造地和商业策略。

2025年关税政策变化所带来的累积影响波及整个医疗设备生态系统的生产经济性、筹资策略和供应链设计。关税压力推高了某些进口零件和成品的相对成本，迫使製造商重新评估其供应商所在地和采购条款。因此，一些製造商加快了近岸外包的步伐，实现了供应商多元化，并寻求签订长期合约以稳定投入价格并维持生产的连续性。

将产品设计、临床应用、医疗保健环境、聚合物选择和分销管道与可操作的商业化和部署途径联繫起来的详细细分见解。

基于产品组成、临床应用、医疗环境、聚合物成分和销售管道等因素评估医疗设备时，细分市场层面的趋势揭示了影响因素和战术性重点。按产品类型划分，市场研究涵盖腰椎导管、脊髓硬膜外导管和脑室导管，每类产品都有其独特的临床操作要求、流量特性和设备整合的考量，这些都会影响临床医生的选择和库存管理。按应用划分，市场研究细分为脑脊髓液漏管理、水脑症、颅内压监测和鞘内给药，治疗目标决定了从流量控製到药物相容性和监测介面等设计重点。

区域分析揭示了美洲、欧洲、中东和非洲以及亚太地区的采用率、法规、采购惯例和供应链成熟度的差异。

区域趋势影响着不同医疗生态系统中的技术应用、监管义务和采购惯例。在美洲，先进手术流程的采用正在稳步推进，重点在于与监测系统的整合。同时，支付方结构和医院采购流程会影响价格谈判和合约期限。相较之下，欧洲、中东和非洲地区的监管环境各异，基础设施成熟度也存在差异，这就要求製造商根据当地的报销机制和医院能力调整临床证据包和支持模式。

深入了解脑脊髓液引流导管领域主要企业的竞争定位、创新策略和商业化策略。

脑脊髓液引流导管领域的竞争格局取决于器材设计的创新、生产规模以及透过培训和上市后监测为临床医生提供支援的能力。主要企业优先考虑差异化的价值提案，这些价值主张不仅限于导管本身，还包括操作培训、灭菌包配置以及与监测系统的兼容性。卓越的生产能力和严格的品管仍然至关重要，因为器械的可靠性和感染控制性能是临床医生信心的关键决定因素。

为製造商和医疗保健系统提供切实可行的策略和营运建议，以扩大设备采用率、提高供应弹性并增强脑脊髓液引流治疗的临床效果。

产业领导企业应优先进行一系列合作倡议，以增强临床可靠性、营运韧性和商业性吸引力。首先，投资于材料和表面创新，显着降低感染风险并改善操作，同时确保透过完善的上市后监测和同行评审期刊发表的论文来累积临床证据。其次，优化包装、留置辅助设备和适用于门诊环境的试剂盒，使产品开发与门诊手术的需求保持一致，从而支持产品向不同临床场所的过渡。

透明的调查方法，说明了主要访谈、二手证据的整合、细分一致性和品管，以深入了解实用设备。

本研究途径结合了结构化的原始研究和全面的二手信息，以确保分析的严谨性和相关性。原始资讯包括对神经外科医生、介入临床医生、采购经理和生产主管的访谈，从而获得关于临床工作流程、医疗设备性能重点和采购限制的第一手观点。二手资讯涵盖了同行评审的临床文献、监管指导文件、医疗设备附加檔和上市公司披露信息，并与原始反馈进行交叉比对，以检验趋势并阐明临床模式的背景。

本文概述了临床、营运和供应链优先事项如何汇聚，并将决定脑脊髓液引流导管领域的未来成功。

总而言之，脑脊髓液引流导管正不断发展，以满足临床需求、监管要求和不断变化的医疗服务模式。材料科学的进步、对感染预防的重视以及向门诊模式的转变，正在影响导管的设计重点和商业化策略。供应链和贸易政策的趋势使得采购的柔软性和总成本透明度至关重要，而区域差异则要求采取因地制宜的市场进入策略，以反映当地的监管和基础设施实际情况。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 脑脊髓液引流导管市场：依产品类型划分

  • 腰椎导管
  • 脊髓硬膜外导管
  • 心室导管

第九章 脑脊髓液引流导管市场：依材料分类

  • 聚乙烯
  • 聚氨酯
  • 硅酮

第十章 脑脊髓液引流导管市场：依应用领域划分

  • 脑脊髓液漏的处理
  • 水脑症
  • 颅内压监测
  • 鞘内给药

第十一章 脑脊髓液引流导管市场：依最终用途划分

  • 门诊手术中心
  • 医院
  • 专科诊所

第十二章 脑脊髓液引流导管市场：依通路划分

  • 直销
  • 销售代理
  • 线上零售

第十三章 脑脊髓液引流导管市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 脑脊髓液引流导管市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 脑脊髓液引流导管市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国脑脊髓液引流导管市场

第十七章：中国脑脊髓液引流导管市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • AngioDynamics, Inc.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Cook Medical, LLC
  • ICU Medical, Inc.
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson Services, Inc.
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • Stryker Corporation
  • Teleflex Incorporated
  • Terumo Corporation
Product Code: MRR-035590447E22

The Cerebrospinal Fluid Drainage Catheter Market was valued at USD 312.33 million in 2025 and is projected to grow to USD 342.65 million in 2026, with a CAGR of 8.90%, reaching USD 567.43 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 312.33 million
Estimated Year [2026] USD 342.65 million
Forecast Year [2032] USD 567.43 million
CAGR (%) 8.90%

Foundational overview explaining how clinical needs, technological advances, and procurement priorities converge to redefine cerebrospinal fluid drainage catheter significance in care delivery

Cerebrospinal fluid drainage catheters sit at the intersection of neurosurgery, critical care, and ambulatory intervention. Advances in device materials, infection mitigation, and procedural guidance have progressively reshaped clinical expectations for drainage catheter safety and functionality. Clinicians increasingly demand devices that enable precise placement, minimize complications, and integrate with monitoring systems, while health systems prioritize supply reliability, cost efficiency, and compliance with evolving regulatory standards.

Against this backdrop, understanding the device landscape requires a clear grasp of clinical use cases, the engineering tradeoffs of polymer selection, and the impact of distribution dynamics on procurement. Innovations in catheter design have been driven by patient-centric goals such as reduced infection risk, improved flow control, and compatibility with imaging and monitoring platforms. At the same time, purchasers and clinicians are focused on device traceability, sterility assurances, and streamlined inventory management. Consequently, strategic stakeholders must balance clinical performance with operational considerations to make informed choices that support both patient outcomes and institutional resilience.

How clinical advancements, infection control priorities, outpatient care growth, and supply chain resilience are jointly transforming the cerebrospinal fluid drainage catheter landscape

The landscape for cerebrospinal fluid drainage catheters is undergoing transformative shifts shaped by converging clinical, technological, and health-system trends. Minimally invasive techniques and image-guided placement have reduced procedure times and complication rates, prompting clinicians to adopt refined catheter designs that support targeted therapies and monitoring. In parallel, the quest for infection prevention has accelerated adoption of surface technologies and procedural protocols that mitigate device-related infections, influencing purchasing decisions and clinical pathways.

Another significant shift is the decentralization of care, with ambulatory surgical centers and specialty clinics assuming a greater share of elective procedures. This trend requires devices that are easy to deploy, maintain consistent quality across diverse settings, and align with outpatient reimbursement models. Moreover, supply chain resilience has emerged as a strategic priority; manufacturers and health systems are investing in diversified sourcing and inventory visibility to minimize disruption. Finally, the integration of digital health elements, such as interoperable monitoring and data capture, is starting to influence device selection criteria, as stakeholders seek solutions that yield clinical insights and operational efficiencies.

Assessment of how 2025 tariff dynamics have reshaped procurement, manufacturing footprints, and commercial strategies across the cerebrospinal fluid drainage catheter value chain

The cumulative impact of tariff policy changes in 2025 has influenced production economics, procurement strategies, and supply chain design across the medical device ecosystem. Tariff pressures have raised the relative cost of certain imported components and finished devices, prompting manufacturers to reassess supplier footprints and procurement terms. As a result, some producers accelerated nearshoring initiatives, diversified vendor bases, and pursued longer-term contracts to stabilize input pricing and maintain manufacturing continuity.

Purchasing organizations responded by revisiting sourcing strategies, increasing demand for transparent total-cost-of-ownership analyses, and negotiating price-protection clauses. In some cases, distributors adjusted channel strategies to absorb short-term cost volatility while working with manufacturers to preserve clinical access and product availability. Regulatory and customs compliance burdens also increased administrative complexity, encouraging companies to invest in enhanced trade compliance capabilities and to explore alternative logistics models. Collectively, these adaptations have reinforced the importance of flexible manufacturing, robust supplier qualification processes, and proactive commercial measures to mitigate tariff-driven disruptions.

Detailed segmentation insights linking product designs, clinical applications, care settings, polymer choices, and distribution channels to practical commercialization and adoption pathways

Segment-level dynamics reveal nuanced drivers and tactical priorities when devices are evaluated by product configuration, clinical application, care setting, polymer composition, and sales channel. Based on Product Type, the market is studied across Lumbar Catheter, Spinal Epidural Catheter, and Ventricular Catheter, and each product class presents distinct clinical handling requirements, flow characteristics, and device integration considerations that influence clinician preference and inventory management. Based on Application, the market is studied across Cerebrospinal Fluid Leak Management, Hydrocephalus, Intracranial Pressure Monitoring, and Intrathecal Drug Delivery, and therapeutic intent guides design priorities from flow regulation to drug compatibility and monitoring interface.

Based on End Use, the market is studied across Ambulatory Surgical Centers, Hospitals, and Specialty Clinics, and the distribution of procedures across these settings affects logistics, training needs, and purchasing cycles. Based on Material, the market is studied across Polyethylene, Polyurethane, and Silicone, and material selection determines flexibility, biocompatibility, and long-term durability, driving engineering trade-offs. Based on Distribution Channel, the market is studied across Direct Sales, Distributors, and Online Retail, and channel choice shapes commercialization strategies, customer support models, and pricing transparency. Taken together, these segmentation lenses enable stakeholders to prioritize development and commercialization choices that align with clinical workflow realities and procurement constraints.

Regional analysis highlighting how adoption, regulation, procurement practices, and supply chain maturity differ across the Americas, Europe Middle East & Africa, and Asia-Pacific regions

Regional dynamics shape technology adoption, regulatory obligations, and procurement practices across distinct healthcare ecosystems. Americas markets display strong adoption of advanced procedural workflows and place a premium on integration with monitoring systems, while payer structures and hospital procurement processes influence pricing negotiations and contract durations. In contrast, Europe, Middle East & Africa exhibits heterogenous regulatory landscapes and variable infrastructure maturity, prompting manufacturers to tailor clinical evidence packages and support models to local reimbursement and hospital capabilities.

Asia-Pacific demonstrates rapid procedural volume growth in many centers of excellence, with manufacturers focusing on scalable training programs and regional manufacturing partnerships to meet demand. Differences in supply chain maturity and local manufacturing capacity further influence lead times and inventory management practices across regions. Across all geographies, stakeholders increasingly evaluate product introduction through the lens of clinical outcomes, cost transparency, and supply resilience, which in turn guides regional go-to-market strategies and investment priorities.

Insights into competitive positioning, innovation strategies, and commercialization tactics that distinguish leading organizations in the cerebrospinal fluid drainage catheter domain

Competitive dynamics in the cerebrospinal fluid drainage catheter arena are defined by innovation in device design, manufacturing scale, and the ability to support clinicians with training and post-market surveillance. Leading firms prioritize differentiated value propositions that extend beyond the catheter itself to include procedural training, sterile kit configurations, and compatibility with monitoring ecosystems. Manufacturing excellence and stringent quality systems remain critical, as device reliability and infection control performance are primary determinants of clinician trust.

Partnerships with hospital systems, clinical research centers, and distribution networks enable manufacturers to accelerate adoption, while selective acquisitions and licensing agreements can fill technology gaps or expand product portfolios. Companies that demonstrate agility in regulatory submission processes and that invest in real-world evidence generation tend to secure stronger clinical adoption. At the same time, the capacity to offer flexible commercial models-such as consignment, bundled service offerings, or outcome-based contracting-differentiates those able to meet evolving procurement preferences and institutional budgetary pressures.

Actionable strategic and operational recommendations for manufacturers and health systems to enhance device adoption, supply resilience, and clinical outcomes in cerebrospinal fluid drainage therapies

Industry leaders should prioritize a set of coordinated actions to solidify clinical credibility, operational resilience, and commercial traction. First, invest in material and surface innovations that demonstrably reduce infection risk and improve handling, ensuring that clinical evidence is generated through robust post-market studies and peer-reviewed publications. Secondly, align product development with outpatient procedural needs by optimizing packaging, placement aids, and kits for ambulatory environments, thereby supporting the shift in care venues.

Third, enhance supply chain visibility by qualifying multiple suppliers for critical polymers and components, implementing inventory management solutions, and exploring regional manufacturing partnerships to reduce lead-time exposure. Fourth, expand clinician engagement through comprehensive training programs, simulation resources, and clinician champions to accelerate adoption and reduce device-related complications. Fifth, develop flexible commercial arrangements that accommodate hospital procurement cycles and support value-based purchasing models, while maintaining transparent pricing structures.

Finally, integrate digital enablement where appropriate, such as interoperable monitoring, traceability features, and analytics that support quality assurance and clinician decision-making. Taken together, these measures will strengthen product differentiation, support sustainable adoption, and protect commercial performance in a dynamic policy and procurement environment.

Transparent research methodology describing primary interviews, secondary evidence synthesis, segmentation alignment, and quality controls applied to generate actionable device insights

The research approach combined structured primary inquiry with comprehensive secondary synthesis to ensure analytical rigor and relevance. Primary inputs included interviews with neurosurgeons, interventional clinicians, procurement leaders, and manufacturing operations executives, which provided first-hand perspectives on clinical workflows, device performance priorities, and sourcing constraints. Secondary sources encompassed peer-reviewed clinical literature, regulatory guidance documents, device labeling, and public company disclosures, which were triangulated against primary feedback to validate trends and contextualize practice patterns.

Data integrity was reinforced through cross-validation across multiple respondent types and geographic markets to capture regional nuances. The analysis also applied a segmentation framework that aligned product classes, clinical applications, end-use settings, material choices, and distribution channels to highlight differential drivers and barriers. Quality control measures included review cycles with clinical advisors and supply chain specialists to ensure factual accuracy and to refine interpretive conclusions. The methodology emphasizes transparent provenance for insight generation and documents assumptions to support reproducibility and client validation.

Concluding synthesis emphasizing how clinical, operational, and supply chain priorities converge to determine future success in the cerebrospinal fluid drainage catheter sector

In summary, cerebrospinal fluid drainage catheters are evolving in response to clinical imperatives, regulatory expectations, and shifting care delivery models. Material science improvements, infection prevention focus, and the migration of procedures to outpatient settings are shaping design priorities and commercialization strategies. Supply chain and trade policy dynamics have elevated the importance of sourcing flexibility and total-cost transparency, while regional differences call for localized go-to-market approaches that reflect regulatory and infrastructure realities.

Strategic stakeholders who integrate clinical evidence generation, robust supply strategies, and clinician engagement programs will be better positioned to capture value and drive sustainable adoption. The path forward favors organizations that balance engineering innovation with operational excellence and that deliver measurable improvements in patient safety and clinician workflow. In this context, a focused, evidence-led approach to product development and commercialization will be essential for long-term success.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Cerebrospinal Fluid Drainage Catheter Market, by Product Type

  • 8.1. Lumbar Catheter
  • 8.2. Spinal Epidural Catheter
  • 8.3. Ventricular Catheter

9. Cerebrospinal Fluid Drainage Catheter Market, by Material

  • 9.1. Polyethylene
  • 9.2. Polyurethane
  • 9.3. Silicone

10. Cerebrospinal Fluid Drainage Catheter Market, by Application

  • 10.1. Cerebrospinal Fluid Leak Management
  • 10.2. Hydrocephalus
  • 10.3. Intracranial Pressure Monitoring
  • 10.4. Intrathecal Drug Delivery

11. Cerebrospinal Fluid Drainage Catheter Market, by End Use

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Hospitals
  • 11.3. Specialty Clinics

12. Cerebrospinal Fluid Drainage Catheter Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Distributors
  • 12.3. Online Retail

13. Cerebrospinal Fluid Drainage Catheter Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Cerebrospinal Fluid Drainage Catheter Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Cerebrospinal Fluid Drainage Catheter Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Cerebrospinal Fluid Drainage Catheter Market

17. China Cerebrospinal Fluid Drainage Catheter Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbott Laboratories
  • 18.6. AngioDynamics, Inc.
  • 18.7. B. Braun Melsungen AG
  • 18.8. Baxter International Inc.
  • 18.9. Becton, Dickinson and Company
  • 18.10. Boston Scientific Corporation
  • 18.11. Cook Medical, LLC
  • 18.12. ICU Medical, Inc.
  • 18.13. Integra LifeSciences Holdings Corporation
  • 18.14. Johnson & Johnson Services, Inc.
  • 18.15. Medtronic plc
  • 18.16. Merit Medical Systems, Inc.
  • 18.17. Stryker Corporation
  • 18.18. Teleflex Incorporated
  • 18.19. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY END USE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY LUMBAR CATHETER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY LUMBAR CATHETER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY LUMBAR CATHETER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY SPINAL EPIDURAL CATHETER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY SPINAL EPIDURAL CATHETER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY SPINAL EPIDURAL CATHETER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY VENTRICULAR CATHETER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY VENTRICULAR CATHETER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY VENTRICULAR CATHETER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY POLYETHYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY POLYETHYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY POLYETHYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY POLYURETHANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY POLYURETHANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY POLYURETHANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY SILICONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY SILICONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY SILICONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY CEREBROSPINAL FLUID LEAK MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY CEREBROSPINAL FLUID LEAK MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY CEREBROSPINAL FLUID LEAK MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY HYDROCEPHALUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY HYDROCEPHALUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY HYDROCEPHALUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY INTRACRANIAL PRESSURE MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY INTRACRANIAL PRESSURE MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY INTRACRANIAL PRESSURE MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY INTRATHECAL DRUG DELIVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY INTRATHECAL DRUG DELIVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY INTRATHECAL DRUG DELIVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY ONLINE RETAIL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY ONLINE RETAIL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. AMERICAS CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 57. AMERICAS CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 58. AMERICAS CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 59. AMERICAS CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 60. AMERICAS CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 62. NORTH AMERICA CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. NORTH AMERICA CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 64. NORTH AMERICA CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 65. NORTH AMERICA CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 66. NORTH AMERICA CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 68. LATIN AMERICA CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. LATIN AMERICA CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 70. LATIN AMERICA CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 71. LATIN AMERICA CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 72. LATIN AMERICA CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 73. LATIN AMERICA CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE, MIDDLE EAST & AFRICA CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE, MIDDLE EAST & AFRICA CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 86. MIDDLE EAST CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. MIDDLE EAST CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. MIDDLE EAST CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 89. MIDDLE EAST CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 90. MIDDLE EAST CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 91. MIDDLE EAST CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 92. AFRICA CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. AFRICA CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. AFRICA CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 95. AFRICA CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 96. AFRICA CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 97. AFRICA CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. ASEAN CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. ASEAN CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. ASEAN CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 108. ASEAN CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. ASEAN CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 110. ASEAN CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 111. GCC CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GCC CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. GCC CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 114. GCC CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 115. GCC CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 116. GCC CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPEAN UNION CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPEAN UNION CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPEAN UNION CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPEAN UNION CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPEAN UNION CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPEAN UNION CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 123. BRICS CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. BRICS CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. BRICS CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 126. BRICS CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. BRICS CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 128. BRICS CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 129. G7 CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. G7 CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. G7 CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 132. G7 CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. G7 CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 134. G7 CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 135. NATO CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. NATO CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. NATO CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 138. NATO CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. NATO CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 140. NATO CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. UNITED STATES CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 143. UNITED STATES CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. UNITED STATES CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 145. UNITED STATES CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 146. UNITED STATES CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 147. UNITED STATES CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 148. CHINA CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 149. CHINA CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. CHINA CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 151. CHINA CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 152. CHINA CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 153. CHINA CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)